The NAFKAM International Registry of Exceptional Courses of Disease Related to the Use of Complementary and Alternative Medicine by Fønnebø, Vinjar et al.
60 Volume 1, Number 1 • March 2012 • www.gahmj.com
GLOBAL ADVANCES IN HEALTH AND MEDICINE
Feature
The increasing use of complementary and alterna-tive medicine (CAM) represents a continuing demand for treatment approaches in parallel 
with, or as an alternative to, conventional healthcare 
delivery.1,2 Some patients report considerable health 
improvements related to their use of CAM,3-6 and others 
report no effect or possibly harm.7 Limited efforts have 
been made so far to systematically collect patients’ per-
sonal experiences with various CAM therapies. Methods 
to collect “best cases” after the use of CAM in cancer 
patients have been initiated in the United States and 
Germany.5,8,9 The focus of these projects has been to 
assess treatment response on outcomes measured inde-
pendently of the patients’ awareness of, experience with, 
and reflections on things such as tumor size or survival.6 
They have either concentrated on one condition or have 
constituted a one-time limited research project. The 
National Research Center in Complementary and 
Alternative Medicine (NAFKAM) in Norway believes it is 
important to monitor positive as well as negative patient 
experiences after the use of CAM, and in 2002, the first 
international registry for long-term collection of excep-
tional “best” and “worst” cases was established. In the 
beginning, only severe and chronic diseases such as can-
cer, multiple sclerosis (MS), asthma and allergy, migraine, 
and chronic fatigue syndrome were included, but the 
registry has since been expanded to include all health 
conditions. The Registry of Exceptional Courses of 
Disease (hereafter referred to as “the Registry”) serves as a 
basis for research on questionnaire data, medical assess-
ments, and interview data from “exceptional” patients’ 
experiences and reflections.3,6
Goals
The purposes of the Registry are to (1) collect 
patient-reported experiences from courses of illness/
disease that have followed a different course than 
expected; (2) make these patient experiences accessible 
to researchers in a searchable format; and (3) monitor 
the collected experiences and refer series of similar 
experiences to researchers and health authorities.
InFrastructure
The Registry is located at NAFKAM’s offices in 
Tromsø, Norway. NAFKAM is part of the Department 
of Community Medicine at the Faculty of Health 
Sciences, University of Tromsø. A steering committee 
has been established (2 researchers from NAFKAM and 
a representative from a national patient organization), 
and a 50% administrative position has been allocated 
to the day-to-day running of the Registry. The Registry 
is 100% funded by NAFKAM, which in turn is funded 
by the Norwegian Ministry of Health and Care Services.
Information about the Registry is available 
through the websites of NAFKAM and the Norwegian 
Information Center on Complementary and Alternative 
Medicine as well as the websites of a number of cooper-
ating patient organizations throughout Scandinavia. 
Doctors, alternative practitioners, and the media also 
provide patients with information about the Registry. 
So far, no paid advertising has been used. 
Data to be included in the Registry can only be 
submitted by the patient him- or herself or by close 
family (if the patient is a child or has passed away). The 
data are collected through a self-administered ques-
tionnaire (on paper) with both open and closed ques-
tions. Topics include demographic information, histo-
ry of diseases, CAM and conventional treatments used, 
and reasons for the “exceptional” classification of the 
disease course. A request is made for informed consent 
for the use of the collected data for research purposes 
and consent for access to medical records from hospi-
tals, general practitioners, and CAM providers. Some 
patients have attached letters, notes, books, etc.
Core information from the questionnaire is 
entered into a database at NAFKAM, and the whole 
questionnaire and the informed consent form are phys-
ically stored, along with medical records collected for 
some cases, in fireproof, locked filing cabinets at 
NAFKAM. The documents are also stored in portable 
document format for future retrieval. The database is 
placed as a part of EUTRO (an information technology 
solution designed to protect and manage biologic mate-
rial, metadata, data, and projects for major health sur-
veys) at the Department of Community Medicine. An 
overview of all available Registry variables can be 
found online (http://www2.uit.no/ikbViewer/page/
a n s a t t e / o r g a n i s a s j o n / h j e m ? p _ d i m e n s i o n _
id=88112&p_menu=42374&p_lang=1). 
eligible Patients
To be included in the Registry, a patient must have 
(1) had a disease/health problem, (2) experienced unex-
pected improvement or worsening of the course of 
disease, and (3) related this improvement or worsening 
to the use of CAM. In the Registry, “exceptional courses 
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of disease” refers to both best and worst courses related 
to the use of CAM. In best courses of disease, patients 
report disease remission, cure, symptom relief, or 
improved survival. In worst courses of disease, patients 
report severe adverse reactions. In best courses of dis-
ease, the patients do not define improvement of their 
courses of disease related to the use of CAM as miracles 
or spontaneous remissions, although their exceptional 
courses of disease can include spiritual or religious 
experiences or practices.3 
Medical assessments
Some reported exceptional courses of disease are 
medically assessed by physicians at NAFKAM and 
external specialists according to a predefined proce-
dure. The assessment is performed on the basis of 
patient records that we have collected with the patient’s 
consent from hospitals and primary care. The purpose 
of this assessment is to determine whether a reported 
course of disease is likely to happen in a similar patient 
undergoing conventional treatment alone. These 
assessments are currently limited to conditions where 
a patient-independent evaluation is possible. A patient-
independent evaluation is an evaluation where there is 
no need for verbal or nonverbal input from the patient 
to achieve a disease status description. The only condi-
tion in the Registry fulfilling this requirement at the 
present time is cancer. The Registry is, however, also 
piloting whether a similar assessment procedure can 
be followed for patients with MS.
The medical assessment makes a conclusion at 3 
possible levels.
1. Not medically exceptional: a physician would 
most likely see this course of disease in at least 
10% of similar patients.
2.  Possibly medically exceptional: a physician would 
most likely see this course of disease in less than 
10% but more than 1% of similar patients.
3. Medically exceptional: a physician would most 
likely see this course of disease in 1% or less of 
similar patients.
research opportunities
Research based on data from the Registry can be 
initiated in 2 ways.
1. Researcher-initiated research: 
Information about the collected data is available on 
the website of the Registry (http://www2.uit.no/
ikbViewer/page/ansatte/organisasjon/hjem?p_
dimension_id=88112&p_menu=42374&p_
lang=1). Any researcher can apply to the Registry 
steering group for access to the data. If the neces-
sary formalities (ethics, etc) are in place, a data set 
will be submitted to the researcher. After ethics 
approval, a researcher is also allowed to contact the 
patient(s), initially via NAFKAM, for further infor-
mation collection by interview, questionnaire, etc. 
2. Registry-initiated research:
When the Registry has received 5 positive cours-
es of similar chronic disease and the same treat-
ment, a pseudonymous report of these 5 cases 
will be transferred to the NAFKAM researchers 
for possible efficacy/effectiveness research. The 
same is done after 3 courses of serious/life-threat-
ening diseases. 
safety warnings
When the Registry has received 3 negative courses 
of similar chronic disease and same treatment, a pseud-
onymous report of these 3 cases will be sent to the 
Directorate of Health in Norway as a warning of a 
potentially harmful treatment. The same is done after 
one negative course of serious/life-threatening disease.
  
results so Far
The Registry has received and registered a total 
number of 322 patient-reported exceptional courses 
of disease (by  December 31, 2011), 317 positive and 5 
negative. Of the cancer and MS courses that have been 
medically assessed, one has been classified as medi-
cally exceptional and 14 have been classified as pos-
sibly exceptional.
The most common conditions the patients have 
been suffering from are cancer, MS, asthma/allergies, 
chronic fatigue syndrome/myalgic encephalomyelitis, 
conditions patients ascribe to dental-filling materials, 
migraine, ulcerous colitis, diabetes, and rheumatic con-
ditions. The most commonly used CAM treatments 
have been massage, acupuncture, reflexology, dietary 
supplements, healing, and homeopathy. 
Published research
Four scientific articles based on data from the 
Registry have been published to date.3,6,10,11 The first 
and second publications are a general description of 
the Registry and a comparative study of the procedures 
used internationally to register and assess exceptional 
courses of disease. Findings from the other 2 publica-
tions are as follows:
1. MS patients change from passive recipients of care 
to active explorers of healthcare independently of 
treatment systems. CAM facilitates the patients’ 
own efforts that are needed for improved health 
and well-being in their lives with MS. 
2. Patients reporting their disease courses as excep-
tionally positive most often also take responsibili-
ty for developing the condition in the first place. 
This creates a basis for handling their disease now 
and in the future, often involving major changes 
in lifestyle and attitude toward the conventional 
healthcare system.
Four additional scientific manuscripts based on 
data from the Registry are under review for publication, 
and one doctoral thesis will be completed in 2012. 
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DIscussIon
Internationally, NAFKAM is, as far as we know, 
the first research institution to establish a registry for 
patients having experienced exceptional courses of 
disease related to CAM treatment(s). Previously, some-
what similar approaches have been limited to positive 
(best) cases after cancer patients’ use of CAM and were 
initiated in the United States and in Germany.5,6,8,9,12 
Characteristics of the NAFKAM Registry that differen-
tiate it from previous efforts/projects are as follows:
1. It is a long-term, ongoing registry.
2. Both positive and negative courses of disease are 
collected.
3. Disease courses are always patient-reported and 
patient-defined. 
4. Medical assessments are based solely on patients’ 
medical records.
The exceptional courses of disease submitted to 
the Registry constitute a self-selected sample of patients 
from Scandinavia. It is therefore important to empha-
size that based on the Registry, it is impossible to estab-
lish incidence or prevalence of being an exceptional 
patient. It may, however, be possible to identify some 
common patterns among patients reporting their dis-
ease courses as exceptional.
The Registry is not intended to be a collection of 
miracles and spontaneous remissions. The term miracle 
implies a relationship to the divine and thereby to 
issues of faith.13,14 Spontaneous means something that 
occurs naturally and not as a consequence of an inter-
vention. Thus, spontaneous remissions are defined as 
recoveries without reason or cause15 and are recog-
nized in many health disorders.16 Spontaneous events 
could also be seen as events without “known” cause, 
and miracles as events where the cause is thought to be 
“divine.” In that understanding, both events could be 
interesting for the Registry. Based consistently on 
patient reports, the Registry has the unique opportuni-
ty of being an important basis for research on the 
patients’ body of knowledge. This body of knowledge 
can include numerous aspects of understanding that 
are normally not included in medical records. This 
body of knowledge has already resulted in valuable 
insight into perspectives that are important for patients 
to understand their diseases and change their behavior. 
These research results are fundamental in building an 
understanding of the context of patients’ CAM use, the 
first step in the NAFKAM research strategy.17 
With medical assessments available for patients 
with cancer and MS, the Registry also can provide 
insight into patient-experienced exceptional disease 
courses from a strictly conventional medicine perspec-
tive. The medical and patient perspectives can be per-
ceived as complementary perspectives underpinning 
different aspects of a chronic disease and living with a 
chronic disease. Our experience so far has shown that 
some of the discrepancies in these 2 perspectives are 
caused partly by a misunderstanding on the patient’s 
part with regard to his or her exact diagnosis. There also 
seems to be an interesting discrepancy between “objec-
tively” measured symptoms and signs of disease on the 
one hand and reported symptom load on the other hand. 
Patients report feeling better even though the “mea-
sured” symptoms and signs may remain unchanged. 
This knowledge can become an important foundation 
for research based on the patients’ experiences.
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